KDR mutations have been associated with cardiac and primary breast angiosarcomas, and in our cohort, KDR was present in 17 (23.3%) of breast angiosarcoma samples, supporting its role in this subtype [27]. This evidence concerns the gene KDR and breast angiosarcoma.